- Home
- KRRO vs ARDC Comparison
KRRO vs ARDC Comparison
Compare KRRO & ARDC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KRRO
- ARDC
- Stock Information
- Founded
- KRRO 2014
- ARDC 2012
- Country
- KRRO United States
- ARDC United States
- Employees
- KRRO N/A
- ARDC N/A
- Industry
- KRRO Biotechnology: Pharmaceutical Preparations
- ARDC Investment Managers
- Sector
- KRRO Health Care
- ARDC Finance
- Exchange
- KRRO Nasdaq
- ARDC Nasdaq
- Market Cap
- KRRO 358.3M
- ARDC 334.0M
- IPO Year
- KRRO 2019
- ARDC N/A
- Fundamental
- Price
- KRRO $38.88
- ARDC $13.50
- Analyst Decision
- KRRO Strong Buy
- ARDC
- Analyst Count
- KRRO 7
- ARDC 0
- Target Price
- KRRO $96.71
- ARDC N/A
- AVG Volume (30 Days)
- KRRO 241.5K
- ARDC 115.8K
- Earning Date
- KRRO 11-12-2025
- ARDC 01-01-0001
- Dividend Yield
- KRRO N/A
- ARDC 9.84%
- EPS Growth
- KRRO N/A
- ARDC N/A
- EPS
- KRRO N/A
- ARDC N/A
- Revenue
- KRRO $6,281,000.00
- ARDC N/A
- Revenue This Year
- KRRO $116.91
- ARDC N/A
- Revenue Next Year
- KRRO N/A
- ARDC N/A
- P/E Ratio
- KRRO N/A
- ARDC N/A
- Revenue Growth
- KRRO N/A
- ARDC N/A
- 52 Week Low
- KRRO $10.29
- ARDC $11.56
- 52 Week High
- KRRO $76.79
- ARDC $14.30
- Technical
- Relative Strength Index (RSI)
- KRRO 47.86
- ARDC 37.84
- Support Level
- KRRO $38.02
- ARDC $13.45
- Resistance Level
- KRRO $40.97
- ARDC $13.58
- Average True Range (ATR)
- KRRO 4.85
- ARDC 0.21
- MACD
- KRRO -1.42
- ARDC 0.04
- Stochastic Oscillator
- KRRO 12.27
- ARDC 48.21
About KRRO Korro Bio Inc.
Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability.
About ARDC Ares Dynamic Credit Allocation Fund Inc.
Ares Dynamic Credit Allocation Fund Inc is a closed-ended, diversified management investment company. The fund's investment objective is to provide an attractive level of total return, through current income and, secondarily, through capital appreciation. The Fund invests in a broad, dynamically managed portfolio of senior secured loans (Senior Loans) made to companies whose debt is rated below investment grade; corporate bonds (Corporate Bonds) that are high yield issues rated below investment grade; other fixed-income instruments of a similar nature that may be represented by derivatives; and securities of collateralized loan obligations (CLOs).